{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:10Z","timestamp":1793911270228,"version":"4.8.0"},"reference-count":131,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,2]]},"DOI":"10.1093\/jnci\/djq562","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T23:04:06Z","timestamp":1296515046000},"page":"368-383","source":"Crossref","is-referenced-by-count":578,"title":["Human Papillomavirus Testing in the Prevention of Cervical Cancer"],"prefix":"10.1093","volume":"103","author":[{"given":"Mark","family":"Schiffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholom","family":"Wacholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,1,31]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","article-title":"International incidence rates of invasive cervical cancer before cytological screening","volume":"71","author":"Gustafsson","year":"1997","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin."},{"issue":"9590","key":"key\n\t\t\t\t20170521001740_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet."},{"key":"key\n\t\t\t\t20170521001740_bib5","volume-title":"Cervix Cancer Screening","author":"International Agency for Research on Cancer","year":"2005"},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib6","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/ijc.24634","article-title":"EUROGIN 2008 roadmap on cervical cancer prevention","volume":"125","author":"Franceschi","year":"2009","journal-title":"Int J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib7","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol."},{"key":"key\n\t\t\t\t20170521001740_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [published online ahead of print June 17, 2010]","author":"Ferlay","year":"2010","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3322\/canjclin.57.2.105","article-title":"Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines","volume":"57","author":"Solomon","year":"2007","journal-title":"CA Cancer J Clin."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch Intern Med."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1155\/2007\/613150","article-title":"Papillomavirus life cycle organization and biomarker selection","volume":"23","author":"Doorbar","year":"2007","journal-title":"Dis Markers."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib18","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1158\/0008-5472.CAN-04-0009","article-title":"Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract","volume":"64","author":"Wentzensen","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology."},{"key":"key\n\t\t\t\t20170521001740_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer."},{"key":"key\n\t\t\t\t20170521001740_bib23","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521001740_bib24","doi-asserted-by":"crossref","first-page":"S3\/11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine."},{"issue":"17","key":"key\n\t\t\t\t20170521001740_bib25","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2006.06.1291","article-title":"Clinical implications of human papillomavirus in head and neck cancers","volume":"24","author":"Fakhry","year":"2006","journal-title":"J Clin Oncol."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodriguez","year":"2010","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","article-title":"Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women","volume":"100","author":"Munoz","year":"2009","journal-title":"Br J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib30","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis."},{"issue":"20","key":"key\n\t\t\t\t20170521001740_bib31","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1158\/0008-5472.CAN-06-1812","article-title":"Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality","volume":"66","author":"Kovacic","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"key\n\t\t\t\t20170521001740_bib32","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/343816","article-title":"Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities","volume":"186","author":"Schiffman","year":"2002","journal-title":"J Infect Dis."},{"key":"key\n\t\t\t\t20170521001740_bib33","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine."},{"issue":"12","key":"key\n\t\t\t\t20170521001740_bib34","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","article-title":"Behavioral\/lifestyle and immunological factors associated with HPV infection among women older than 45 years of age","volume":"19","author":"Gonzalez","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"14","key":"key\n\t\t\t\t20170521001740_bib35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1055-9965.EPI-08-1012","article-title":"Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women","volume":"18","author":"Trottier","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"24","key":"key\n\t\t\t\t20170521001740_bib37","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170521001740_bib40","doi-asserted-by":"crossref","first-page":"S3\/52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J Infect Dis."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib42","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","author":"Barnabas","year":"2006","journal-title":"PLoS Med."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00006250-198605000-00012","article-title":"Behavior of mild cervical dysplasia during long-term follow-up","volume":"67","author":"Nasiell","year":"1986","journal-title":"Obstet Gynecol."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0002-9378(69)90268-3","article-title":"A follow-up study of patients with cervical dysplasia","volume":"105","author":"Richart","year":"1969","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1055-9965.EPI-08-1186","article-title":"Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies","volume":"18","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"9599","key":"key\n\t\t\t\t20170521001740_bib47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib49","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ijc.21953","article-title":"Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies","volume":"119","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2006","journal-title":"Int J Cancer."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib50","first-page":"1021","article-title":"An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)","volume":"10","author":"Castle","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"23","key":"key\n\t\t\t\t20170521001740_bib51","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djq436","article-title":"Chlamydia trachomatis and Risk of Prevalent and Incident Cervical Premalignancy in a Population-Based Cohort","volume":"102","author":"Safaeian","year":"2010","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0168-1702(02)00191-0","article-title":"Host and viral genetics and risk of cervical cancer: a review","volume":"89","author":"Hildesheim","year":"2002","journal-title":"Virus Res."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/COH.0b013e32831a7246","article-title":"Human papillomavirus-related disease in people with HIV","volume":"4","author":"Palefsky","year":"2009","journal-title":"Curr Opin HIV AIDS."},{"issue":"22","key":"key\n\t\t\t\t20170521001740_bib54","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1158\/0008-5472.CAN-06-2034","article-title":"Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women","volume":"66","author":"Garc\u00eda-Pi\u00f1eres","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521001740_bib55","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jadohealth.2008.07.009","article-title":"Age-specific prevalence of infection with human papillomavirus in females: a global review","volume":"43","author":"Smith","year":"2008","journal-title":"J Adolesc Health."},{"key":"key\n\t\t\t\t20170521001740_bib56","volume-title":"SEER Cancer Statistics Review, 1975\u20132007","author":"Altekruse"},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib57","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.2910440108","article-title":"Risk factors for cervical cancer in Greenland and Denmark: a population-based cross-sectional study","volume":"44","author":"Kjaer","year":"1989","journal-title":"Int J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib59","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis."},{"key":"key\n\t\t\t\t20170521001740_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-2042-8","volume-title":"The Bethesda System for Reporting Cervical Cytology","author":"Solomon","year":"2004","edition":"2nd ed"},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jnci\/92.5.397","article-title":"Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group","volume":"92","author":"The Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.","year":"2000","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib64","first-page":"973","article-title":"Where\u2019s the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses","volume":"91","author":"Kinney","year":"1998","journal-title":"Obstet Gynecol."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1097-0142(19990425)87:2<48::AID-CNCR2>3.0.CO;2-D","article-title":"Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma","volume":"87","author":"Hutchinson","year":"1999","journal-title":"Cancer."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib67","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib68","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol."},{"issue":"16","key":"key\n\t\t\t\t20170521001740_bib70","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA."},{"issue":"7609","key":"key\n\t\t\t\t20170521001740_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"issue":"16","key":"key\n\t\t\t\t20170521001740_bib73","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.22677","article-title":"Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months","volume":"121","author":"Bulk","year":"2007","journal-title":"Int J Cancer."},{"issue":"16","key":"key\n\t\t\t\t20170521001740_bib75","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med."},{"issue":"14","key":"key\n\t\t\t\t20170521001740_bib76","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med."},{"issue":"9601","key":"key\n\t\t\t\t20170521001740_bib77","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet."},{"issue":"14","key":"key\n\t\t\t\t20170521001740_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170521001740_bib79","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib80","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ogc.2008.09.005","article-title":"Cervical cancer screening in the early post vaccine era","volume":"35","author":"Waxman","year":"2008","journal-title":"Obstet Gynecol Clin North Am."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170521001740_bib82","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521001740_bib83","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jnci\/dji014","article-title":"A study of the impact of adding HPV types to cervical cancer screening and triage test","volume":"97","author":"Schiffman","year":"2005","journal-title":"J Natl Cancer Inst."},{"issue":"8","key":"key\n\t\t\t\t20170521001740_bib85","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of hybrid capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"J Clin Microbiol."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2006.01.091","article-title":"Colposcopy at a crossroads","volume":"195","author":"Jeronimo","year":"2006","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib87","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1055-9965.EPI-07-2904","article-title":"A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study","volume":"17","author":"Gravitt","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"9328","key":"key\n\t\t\t\t20170521001740_bib88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(02)09463-1","article-title":"Viral load of human papillomavirus and risk of CIN3 or cervical cancer","volume":"360","author":"Lorincz","year":"2002","journal-title":"Lancet."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","article-title":"Special commentary: patient safety and the next generation of HPV DNA tests","volume":"134","author":"Kinney","year":"2010","journal-title":"Am J Clin Pathol."},{"issue":"12","key":"key\n\t\t\t\t20170521001740_bib90","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/ijc.23012","article-title":"High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease","volume":"121","author":"Gravitt","year":"2007","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.23940","article-title":"High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer","volume":"124","author":"Hesselink","year":"2009","journal-title":"Int J Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib93","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","author":"ASCUS-LSIL Traige Study (ALTS) Group.","year":"2003","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib95","doi-asserted-by":"crossref","first-page":"356 e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib96","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejca.2006.11.013","article-title":"HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology","volume":"43","author":"Ronco","year":"2007","journal-title":"Eur J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib97","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncr.21844","article-title":"Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes","volume":"108","author":"Sherman","year":"2006","journal-title":"Cancer."},{"issue":"2, pt 1","key":"key\n\t\t\t\t20170521001740_bib98","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/AOG.0b013e3181c799a3","article-title":"Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks","volume":"115","author":"Castle","year":"2010","journal-title":"Obstet Gynecol."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib99","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis Markers."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib101","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cncr.22420","article-title":"Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia","volume":"111","author":"Wentzensen","year":"2007","journal-title":"Cancer."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib103","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","article-title":"p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis","volume":"35","author":"Tsoumpou","year":"2009","journal-title":"Cancer Treat Rev."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib104","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/AJCP3CD9YKYFJDQL","article-title":"The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results","volume":"134","author":"Denton","year":"2010","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/LGT.0b013e31819308d4","article-title":"The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia","volume":"13","author":"Massad","year":"2009","journal-title":"J Low Genit Tract Dis."},{"issue":"2","key":"key\n\t\t\t\t20170521001740_bib107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib108","doi-asserted-by":"crossref","first-page":"47.e1","DOI":"10.1016\/j.ajog.2007.02.047","article-title":"Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type","volume":"197","author":"Jeronimo","year":"2007","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib109","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/AOG.0b013e31816baed1","article-title":"Interobserver agreement in the assessment of components of colposcopic grading","volume":"111","author":"Massad","year":"2008","journal-title":"Obstet Gynecol."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib110","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ijc.22991","article-title":"Inappropriate gold standard bias in cervical cancer screening studies","volume":"121","author":"Pretorius","year":"2007","journal-title":"Int J Cancer."},{"key":"key\n\t\t\t\t20170521001740_bib111","article-title":"The accuracy of colposcopic biopsy: analyses from the placebo arm of the gardasil clinical trials [published online ahead of print May 20, 2010]","author":"Stoler","year":"2010","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib112","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib113","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","article-title":"The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study","volume":"132","author":"Dalla Palma","year":"2009","journal-title":"Am J Clin Pathol."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib115","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1067\/mob.2003.456","article-title":"Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study","volume":"188","author":"Guido","year":"2003","journal-title":"Am J Obstet Gynecol."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib116","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ctrv.2006.07.008","article-title":"The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group (C5 group) approach","volume":"32","author":"Kyrgiou","year":"2006","journal-title":"Cancer Treat Rev."},{"issue":"9509","key":"key\n\t\t\t\t20170521001740_bib117","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet."},{"issue":"5","key":"key\n\t\t\t\t20170521001740_bib118","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"1","key":"key\n\t\t\t\t20170521001740_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1055-9965.EPI-06-0710","article-title":"Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3","volume":"16","author":"Kreimer","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"8","key":"key\n\t\t\t\t20170521001740_bib120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/0003-4819-151-8-200910200-00007","article-title":"Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States","volume":"151","author":"Kim","year":"2009","journal-title":"Ann Intern Med."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib121","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/OLQ.0b013e3181bce102","article-title":"The use of human papillomavirus seroepidemiology to inform vaccine policy","volume":"36","author":"Schiffman","year":"2009","journal-title":"Sex Transm Dis."},{"issue":"10","key":"key\n\t\t\t\t20170521001740_bib122","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res (Phila)."},{"issue":"9686","key":"key\n\t\t\t\t20170521001740_bib123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet."},{"issue":"7","key":"key\n\t\t\t\t20170521001740_bib124","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA."},{"issue":"6","key":"key\n\t\t\t\t20170521001740_bib125","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change","volume":"40","author":"Franco","year":"2009","journal-title":"Arch Med Res."},{"issue":"3","key":"key\n\t\t\t\t20170521001740_bib126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cncr.22751","article-title":"Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing","volume":"111","author":"Schiffman","year":"2007","journal-title":"Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521001740_bib127","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(09)70253-0","article-title":"Risk estimation for the next generation of prevention programmes for cervical cancer","volume":"10","author":"Katki","year":"2009","journal-title":"Lancet Oncol."},{"key":"key\n\t\t\t\t20170521001740_bib128","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ."},{"issue":"4","key":"key\n\t\t\t\t20170521001740_bib129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10552-008-9256-0","article-title":"Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study","volume":"20","author":"Clegg","year":"2009","journal-title":"Cancer Causes Control."},{"key":"key\n\t\t\t\t20170521001740_bib130","doi-asserted-by":"crossref","first-page":"K76","DOI":"10.1016\/j.vaccine.2008.06.009","article-title":"Modeling cervical cancer prevention in developed countries","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521001740_bib131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2407-10-111","article-title":"A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)","volume":"10","author":"Ogilvie","year":"2010","journal-title":"BMC Cancer."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/103\/5\/368\/17311365\/djq562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T12:58:42Z","timestamp":1712149122000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djq562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,31]]},"references-count":131,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,1,31]]},"published-print":{"date-parts":[[2011,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djq562","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,31]]}}}